Oppenheimer Asset Management Inc. Astrazeneca PLC Transaction History
Oppenheimer Asset Management Inc.
- $6.65 Billion
- Q1 2024
A detailed history of Oppenheimer Asset Management Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 87,416 shares of AZN stock, worth $6.73 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
87,416
Previous 87,969
0.63%
Holding current value
$6.73 Million
Previous $5.92 Million
0.03%
% of portfolio
0.09%
Previous 0.08%
Shares
25 transactions
Others Institutions Holding AZN
# of Institutions
1,247Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.72 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.78 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.31 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.66 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.33 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $239B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...